{"id":"https://openalex.org/W4239757889","doi":"https://doi.org/10.1093/ibd/izy037.028","title":"13 REFINED POPULATION PHARMACOKINETIC MODEL FOR INFLIXIMAB PRECISION DOSING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE","display_name":"13 REFINED POPULATION PHARMACOKINETIC MODEL FOR INFLIXIMAB PRECISION DOSING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE","publication_year":2018,"publication_date":"2018-01-18","ids":{"openalex":"https://openalex.org/W4239757889","doi":"https://doi.org/10.1093/ibd/izy037.028"},"language":"en","primary_location":{"id":"doi:10.1093/ibd/izy037.028","doi":"https://doi.org/10.1093/ibd/izy037.028","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izy037.028","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080488710","display_name":"Laura E. Bauman","orcid":"https://orcid.org/0000-0002-9753-5946","observed_orcids":["https://orcid.org/0000-0002-9753-5946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura E Bauman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101737223","display_name":"Ye Xiong","orcid":"https://orcid.org/0000-0001-9770-6031","observed_orcids":["https://orcid.org/0000-0001-9770-6031"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ye Xiong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016058238","display_name":"Tomoyuki Mizuno","orcid":"https://orcid.org/0000-0002-8471-9826","observed_orcids":["https://orcid.org/0000-0002-8471-9826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomoyuki Mizuno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013881333","display_name":"Tsuyoshi Fukuda","orcid":"https://orcid.org/0000-0002-0477-3102","observed_orcids":["https://orcid.org/0000-0002-0477-3102"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tsuyoshi Fukuda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Min Dong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Dong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101762950","display_name":"Michael J. Rosen","orcid":"https://orcid.org/0000-0002-5149-718X","observed_orcids":["https://orcid.org/0000-0002-5149-718X","https://orcid.org/0000-0002-8842-6692"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J Rosen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5040060343","display_name":"Alexander A. T. M. M. Vinks","orcid":"https://orcid.org/0000-0003-4224-2967","observed_orcids":["https://orcid.org/0000-0003-4224-2967"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander A Vinks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3862,"currency":"USD","value_usd":3862},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"suppl_1","first_page":"S58","last_page":"S58"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.8095999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.8095999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.17880000174045563,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9257664084434509},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8923043012619019},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.7935812473297119},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7589526176452637},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.647729218006134},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5625407695770264},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5481798648834229},{"id":"https://openalex.org/C2910800852","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough Concentration","level":3,"score":0.5212402939796448},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.4824238717556},{"id":"https://openalex.org/C31785415","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough level","level":4,"score":0.4738105833530426},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.46676111221313477},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43383294343948364},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.31696194410324097},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.0},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ibd/izy037.028","doi":"https://doi.org/10.1093/ibd/izy037.028","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izy037.028","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2962783208","https://openalex.org/W3168817135","https://openalex.org/W1759963899","https://openalex.org/W4207073345","https://openalex.org/W4391232083","https://openalex.org/W4415664795","https://openalex.org/W2960185068","https://openalex.org/W2913750266","https://openalex.org/W4399442719","https://openalex.org/W2586142976"],"abstract_inverted_index":{"Standard":[0],"weight-based":[1],"infliximab":[2],"(IFX)":[3],"dosing":[4,52],"for":[5,25,68,88],"inflammatory":[6],"bowel":[7],"disease":[8,22,103,127],"(IBD)":[9],"results":[10],"in":[11,15,27,53,71,168,182,273],"long-term":[12],"clinical":[13],"remission":[14],"only":[16],"40\u201360%":[17],"of":[18,59,100,140,221,238,243,247,284],"patients.":[19],"Patient":[20],"and":[21,105,111,132,191,204,209,240,262],"factors":[23],"account":[24],"variability":[26,220],"IFX":[28,32,51,69,91,123,165,196,231,267],"exposure.":[29],"Achieving":[30],"optimal":[31],"exposure":[33],"as":[34,135,282],"assessed":[35,126],"by":[36,146,223],"pre-dose":[37],"trough":[38,124,268],"levels":[39,125,269],"is":[40],"associated":[41,212],"with":[42,74,98,116,171,178,213,235,245],"improved":[43],"outcomes.":[44],"Clinical":[45],"tools":[46],"are":[47],"needed":[48],"to":[49,63,195],"personalize":[50],"a":[54,94,183,236,241,285],"dynamic":[55],"fashion.":[56],"The":[57,82,137,150,227,276],"aim":[58],"this":[60],"study":[61],"was":[62,86,144,167],"refine":[64],"the":[65,141],"existing":[66],"models":[67],"pharmacokinetics":[70],"pediatric":[72,95,274],"patients":[73,89,152],"IBD":[75],"on":[76],"maintenance":[77,122,271],"therapy":[78,272],"using":[79,121],"real-practice":[80],"data.":[81],"electronic":[83],"medical":[84,96],"record":[85],"queried":[87],"receiving":[90],"infusions":[92],"at":[93],"center":[97],"diagnoses":[99],"IBD,":[101],"Crohn\u2019s":[102],"(CD),":[104],"ulcerative":[106],"colitis":[107],"between":[108],"January":[109],"2011":[110],"March":[112],"2017.":[113],"PK":[114,256],"analysis":[115],"Nonlinear":[117],"Mixed":[118],"Effect":[119],"Modeling":[120],"activity":[128],"indices,":[129],"laboratory":[130],"values,":[131],"demographic":[133],"data":[134],"covariates.":[136],"predictive":[138],"performance":[139],"final":[142,184],"model":[143,185,228,257,277],"tested":[145],"ROC":[147],"curve":[148],"analysis.":[149],"147":[151],"included:":[153],"55":[154],"(37%)":[155],"female,":[156],"111":[157],"(76%)":[158],"CD,":[159],"mean":[160],"14.2":[161],"years":[162],"old.":[163],"Mean":[164],"clearance":[166,222],"good":[169],"agreement":[170],"previously":[172],"reported":[173],"values.":[174],"Stepwise":[175],"covariate":[176],"modeling":[177],"backward":[179],"elimination":[180],"resulted":[181],"including":[186,258],"body":[187,206],"weight,":[188,207,259],"albumin,":[189,260],"ESR,":[190,208,261],"ordinal":[192],"antibodies":[193],"(ATI)":[194],"(<22,":[197],"22\u2013200,":[198],"200\u20131000,":[199],">1000":[200],"ng/mL).":[201],"Lower":[202],"albumin":[203],"higher":[205],"ATI":[210,263],"were":[211],"increased":[214],"clearance.":[215],"These":[216],"covariates":[217],"reduced":[218],"inter-individual":[219],"47%":[224],"(Fig.":[225],"1).":[226],"predicted":[229],"an":[230],"level":[232],">5":[233],"ug/mL":[234],"sensitivity":[237],"83.3%":[239],"specificity":[242],"77.4%,":[244],"AUC":[246],"0.907":[248],"(95%":[249],"CI:":[250],"0.886\u20130.937;":[251],"Fig.":[252],"2).":[253],"A":[254],"population":[255],"categories":[264],"accurately":[265],"predicts":[266],"during":[270],"IBD.":[275],"will":[278],"be":[279],"prospectively":[280],"evaluated":[281],"part":[283],"Bayesian":[286],"adaptive":[287],"control":[288],"strategy.":[289]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-05-12T00:00:00"}